(4) - ((s) -3-Fluoro-3- (2- (5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl) ethyl) citrate salt pyrrolidin-1-yl) -3- (3- (2-methoxyethoxy) phenyl) butanoic

摘要

The invention relates to a compound which is (1) -4 - ((s) -3-fluoro-3- (2- (5,6,7,8-tetrahydro) acid (1: 1) citrate salt -1,8-naphthyridin-2-yl) ethyl) pyrrolidin-1-yl) -3- (3- (2-methoxyethoxy) phenyl) butanoic pharmaceutical compositions including such a compound and the use of such a compound in therapy including treating a disease or condition to which an avß6 integrin antagonist is indicated, and in particular idiopathic pulmonary fibrosis.